Literature DB >> 8848006

6-Coumarin diazonium salt: a specific affinity label of the Torpedo acetylcholinesterase peripheral site.

I Schalk1, L Ehret-Sabatier, Y Le Feuvre, S Bon, J Massoulie, M Goeldner.   

Abstract

A 6-coumarin diazonium salt was synthesized and tested on Torpedo acetylcholinesterase as a site-directed irreversible probe for quaternary ammonium binding. The rate of the inactivation was examined as a function of time, inhibitor concentration, and pH, which allowed the determination of the dissociation and the rate constants of this efficient affinity labeling process. Protection experiments using tetramethylammonium, edrophonium, and propidium demonstrated that the labeling reaction occurred exclusively at the peripheral quaternary ammonium binding site of the enzyme. This result was confirmed by the modification of propidium binding at the peripheral site after inactivation reaction, as directly determined by fluorescence. Mutations of the likely labeled amino acid residues, Tyr70 and Tyr121, by histidine and phenylalanine indicated a predominant involvement of Tyr70 over Tyr121 in the coupling reaction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8848006

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  3 in total

1.  Back-scattering interferometry: an ultrasensitive method for the unperturbed detection of acetylcholinesterase-inhibitor interactions.

Authors:  Gabrielle L Haddad; Sherri C Young; Ned D Heindel; Darryl J Bornhop; Robert A Flowers
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-04       Impact factor: 15.336

2.  Coumarin Triazabutadienes for Fluorescent Labeling of Proteins.

Authors:  Mehrdad Shadmehr; Garrett J Davis; Bereketab T Mehari; Stephanie M Jensen; John C Jewett
Journal:  Chembiochem       Date:  2018-11-15       Impact factor: 3.164

3.  Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study.

Authors:  Kimia Hirbod; Leili Jalili-Baleh; Hamid Nadri; Seyed Esmaeil Sadat Ebrahimi; Alireza Moradi; Bahar Pakseresht; Alireza Foroumadi; Abbas Shafiee; Mehdi Khoobi
Journal:  Iran J Basic Med Sci       Date:  2017-06       Impact factor: 2.699

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.